Cargando…
Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer
Adjuvant endocrine therapy (AET) is generally proposed to all patients with hormone receptor-positive breast cancer to reduce the risk of recurrence and death. Adherence to therapy is crucial. However, non-adherence to AET is common, with estimates of up to 50% of patients not successfully completin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450184/ https://www.ncbi.nlm.nih.gov/pubmed/34552323 http://dx.doi.org/10.2147/PPA.S285768 |